HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category
March 26, 2026 | AI, Avatars, Innovation, artificial intelligence, market research
Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of AI to deliver real-world impact. Awarded by the Business Intelligence Group, HRW was recognized for its work using AI avatars to simulate doctor–patient consultations, enabling more realistic and scalable exploration of clinical interactions in market research. The approach has generated valuable insights into both clinician and patient behaviours, supporting better-informed decision-making. The award highlights HRW’s continued investment in advanced methodologies and its role in driving practical applications of AI in healthcare research.
Healthcare Research Worldwide (HRW), today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards, in the Pharmaceutical Category. Presented by the Business Intelligence Group, the award recognizes organizations, products, teams, and individuals that are applying artificial intelligence in ways that drive real, measurable impact.
The 2026 Artificial Intelligence Excellence Awards honour achievement across a broad range of industries and use cases, spotlighting the companies and leaders moving AI beyond experimentation and into practical, accountable deployment. This year’s program recognized winners across 36 industries and more than 15 countries.
The HRW Innovation team was recognized for its pioneering work in AI avatars to simulate both doctors and patients. Through this work, the team were able to replicate the complexity of real-world clinical consultations, an area that has traditionally been difficult to capture in market research. HRW’s approach used AI-driven avatars to simulate these complex interactions, enabling more realistic exploration of how symptoms are described, how physicians respond, and how treatment discussions unfold. The study demonstrated strong methodological and commercial value, producing rich insights into both clinician and patient behaviours, while opening new possibilities for capturing the nuances of real-world consultations in a scalable and controlled way.
This recognition underscores HRW’s continued investment in advanced methodologies and its role at the forefront of integrating artificial intelligence into healthcare research.
“AI has arrived! 2026 is about execution, accountability, and results,” said Russ Fordyce, Chief Recognition Officer, Business Intelligence Group. “HRW stood out because its work in Pharmaceuticals reflects where the market is headed: practical AI that solves real problems, earns trust, and delivers measurable value. This recognition highlights a team that is not just participating in the AI shift but helping define what meaningful progress looks like.”
Christine Dalzell, Global Managing Director for HRW:
“Winning this award is a testament to our commitment to pushing the boundaries of innovation in healthcare research. Our AI avatar approach enables a deeper understanding of real-world interactions between doctors and patients, ultimately helping our clients make better, more informed decisions that benefit patient outcomes.”.
To learn more about the 2026 Artificial Intelligence Excellence Awards, visit:
https://www.bintelligence.com/awards/artificial-intelligence-excellence-awards
This content was provided by Healthcare Research Worldwide
Company Details
Latest Content from Healthcare Research Worldwide
HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category
Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of AI to deliver real-world impact....
HRW’s Environmental Efforts Recognised with ‘B’ for Transparency by CDP
HRW has been recognised by CDP, the global environmental disclosure organisation, for its commitment to sustainability and environmental transparency. In its first submission to CDP’s SME questionnaire, HRW achieved a...
HRW strengthens senior US team with two new Vice Presidents in Manhattan
HRW has announced the appointment of Tina Sallustio and Lauren O’Malley as Vice Presidents in its Manhattan office, reinforcing the agency’s senior leadership team.